Section Arrow
Quote
INBX.NASDAQ
- Inhibrx Biosciences Inc.
Quotes are at least 15-min delayed:2026/08/31 16:46 EDT
After Hours
Last
 126.6809
-0.0191 (-0.02%)
Bid
126.43
Ask
126.81
High 126.7 
Low 125.62 
Volume 5.05K 
Regular Hours (Closed)
Last
 126.7
+3.29 (+2.67%)
Day High 
128.87 
Prev. Close
123.41 
1-M High
131.01 
Volume 
388.96K 
Bid
126.43
Ask
126.81
Day Low
121.59 
Open
123.39 
1-M Low
77.505 
Market Cap 
1.82B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 109.12 
20-SMA 99.25 
50-SMA 94.19 
52-W High 155.29 
52-W Low 26.19 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-8.88/-8.47
Enterprise Value
1.92B
Balance Sheet
Book Value Per Share
-3.60
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
1.30M
Operating Revenue Per Share
0.04
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
CLGNCollPlant Biotechnologies Ltd0.3879+0.0299+8.35%-- 
After Hours 0.3631 -0.0248 -6.39%
AIMAIM ImmunoTech Inc.0.226-0.0324-12.54%-- 
After Hours 0.245 +0.019 +8.41%
ROIVRoivant Sciences Ltd34.64-0.07-0.20%-- 
After Hours 34.45 -0.19 -0.55%
CVKDCadrenal Therapeutics Inc1.75+0.21+13.64%-- 
After Hours 1.69 -0.06 -3.43%
MRNAModerna140.34+2.35+1.70%-- 
After Hours 139.4 -0.94 -0.67%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.